JP Morgan Chase
NITE

JP Morgan Chase’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

JP Morgan Chase’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,066
Closed -$306K – 6171
2019
Q1 		$306K Sell
12,066
-7,840
-39% -$139K ﹤0.01% 4440
2018
Q4 		$229K Buy
19,906
+9,443
+90% +$126K ﹤0.01% 4530
2018
Q3 		$214K Buy
+10,463
New +$215K ﹤0.01% 4667

JP Morgan Chase's NITE Position: Q2 2019 in Review

JP Morgan Chase sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 12,066 shares — an estimated $306K sold.

JP Morgan Chase first reported a position in NITE in Q3 2018 and held it in 3 quarters. The position peaked at $306K in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • JP Morgan Chase reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Chase sold 12,066 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $306K.
  • JP Morgan Chase first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2018 and held it in 3 quarters.
  • JP Morgan Chase's Nightstar Therapeutics plc American Depositary Shares position peaked at $306K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.